MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1101/2024.09.04.611031

Медицинская библиотека · bioRxiv : the preprint server for biology · 2024

Systemic in utero gene editing as a treatment for cystic fibrosis.

Ricciardi Adele S, Barone Christina, Putman Rachael, Quijano Elias, Gupta Anisha, Nguyen Richard, Mandl Hanna, Piotrowski-Daspit Alexandra S, Lopez-Giraldez Francesc, Luks Valerie, Freedman-Weiss Mollie R, Farrelly James, Ahle Samantha, Glazer Peter M, Saltzman W Mark, Stitelman David H, Egan Marie E

СтатьяПрепринтПеревод пока не подготовлен

Аннотация

In utero gene editing has the potential to modify disease causing genes in multiple developing tissues before birth, possibly allowing for normal organ development, disease improvement, and conceivably, cure. In cystic fibrosis (CF), a disease that arises from mutations in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene, there are signs of multiorgan disease affecting the function of the respiratory, gastrointestinal, and reproductive systems already present at birth. Thus, treating CF patients early is crucial for preventing or delaying irreversible organ damage. Here we demonstrate proof-of-concept of multiorgan mutation correction in CF using peptide nucleic acids (PNAs) encapsulated in polymeric nanoparticles and delivered systemically in utero. In utero editing was associated with sustained postnatal CFTR activity, at a level similar to that of wild-type mice, in both respiratory and gastrointestinal tissue, without detection of off-target mutations in partially homologous loci. This work suggests that systemic in utero gene editing represents a viable strategy for treating monogenic diseases before birth that impact multiple tissue types.

Для цитирования: Ricciardi Adele S, Barone Christina, Putman Rachael, Quijano Elias, Gupta Anisha, Nguyen Richard, Mandl Hanna, Piotrowski-Daspit Alexandra S, Lopez-Giraldez Francesc, Luks Valerie, Freedman-Weiss Mollie R, Farrelly James, Ahle Samantha, Glazer Peter M, Saltzman W Mark, Stitelman David H, Egan Marie E. Systemic in utero gene editing as a treatment for cystic fibrosis.. bioRxiv : the preprint server for biology. 2024. DOI: 10.1101/2024.09.04.611031.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.